Hair Cell Loss Induced by Sphingosine and a Sphingosine Kinase Inhibitor in the Rat Cochlea

Abstract

Sphingolipid metabolites including ceramide, sphingosine (Sph), and sphingosine-1-phosphate (S1P) play important roles in the regulation of cell survival and death. Sphingosine kinase (Sk) phosphorylates Sph to S1P. Sk is reportedly overexpressed in various cancer cells, and Sk inhibitors are therefore a target of anti-tumor therapy. However, the effects of Sph and Sk inhibitors on cochlear hair cells were unknown. In the present study, expression of Sk isotypes in the cochlea was examined. In addition, the changes in Sk activity induced by cisplatin (CDDP) and the effects of an Sk inhibitor, Sph and S1P on CDDP ototoxicity were investigated using tissue culture techniques. Cochleae were dissected from Sprague-Dawley rats on postnatal days 3 to 5. Organ of Corti explants were exposed to 5 μM CDDP for 48 h with or without the Sk inhibitor, Sph, or S1P. Both Sk1 and Sk2 were expressed in the normal cochlea. CDDP activated Sk. The Sk inhibitor itself caused hair cell loss at a high concentration, and at lower concentrations it increased CDDP-induced hair cell loss. Sph itself also induced hair cell death and increased hair cell loss induced by CDDP. However, S1P decreased hair cell loss induced by CDDP. Sk inhibitor has the function by increasing ototoxic Sph and decreasing otoprotective S1P, and therefore potentially cause ototoxicity. Consideration of the possibility of ototoxicity is required in the usage of Sk inhibitors.

Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy

“…The authors demonstrated that administration of an antagonist for S1P 2 , but not S1P 1 and S1P 3 , results in increased gentamycin ototoxicity 43 . They further show that inhibition of sphingosine kinase potentiates cisplatin ototoxicity and itself promotes apoptosis and hair cell loss 44 , which confirms the importance of endogenous S1P signalling in cochlear integrity. Additionally, S1P signalling has been implicated in other cellular and physiological functions in the inner ear 45 .…”

Loss of Sphingosine Kinase Alters Life History Traits and Locomotor Function in Caenorhabditis elegans

“…With aging, there could be a lower rate of recruitment of sphingolipid metabolic enzymes such as sphingosine kinase, leading to higher cellular levels of ceramide and sphingosine and lower levels of S1P, ultimately leading to decreased neuronal function. Indeed, inhibition of sphingosine kinase and sphingosine itself mediate hair cell loss in cochlear cells of rats, whereas S1P decreased hair cell loss (Romero-Guevara et al, 2015 ; Tani et al, 2016 ). Furthermore, regulation of S1P levels may impact neurodegenerative disorders.…”

NO and HNO donors, nitrones, and nitroxides: Past, present, and future

“…Interestingly, other potential pharmacological applications have been recently explored, namely those related with Alzheimer's disease. Low concentrations of SNP (0.01 and 0.1 μM) effectively decreased β‐amyloid production through inhibition of amyloidogenic processing of amyloid precursor protein, while higher concentrations (10 and 20 μM) yielded the opposite outcome …”

“…Low concentrations of SNP (0.01 and 0.1 M) effectively decreased -amyloid production through inhibition of amyloidogenic processing of amyloid precursor protein, while higher concentrations (10 and 20 M) yielded the opposite outcome. 32 Organic nitrates have a rapid onset in lowering blood and cardiac filling pressures, thus being frequently used to treat acute cardiovascular events. 33 GTN (Fig.…”